Digital transformation of clinical research: facilitating decentralized clinical trials in India
DOI:
https://doi.org/10.18203/2349-3259.ijct20252205Keywords:
Decentralized clinical trials, India, e-consent, Telehealth, Clinical researchAbstract
The decentralized clinical trials make clinical research accessible by using digital tools such as e-consent, telehealth, and remote monitoring. Decentralized clinical trials in India have the potential to reduce participant burden and increase trial participation. However, the nation's disparate healthcare system, digital divide, and changing regulatory environment make broad adoption difficult. The current status of decentralized clinical trials in India is examined in this review, including significant operational, regulatory gaps, and potential implementation strategies. The aim is to offer information which will help in scaling decentralized clinical trials in India. This review compiles findings from journals, regulatory guidelines, white papers, blogs and case studies from Indian decentralized clinical trial platforms. It focuses on trends, logistical challenges, regulatory readiness in decentralized clinical trials implementation in the Indian context. To support key details tables and figures are used. India's pilot decentralized clinical trials demonstrate increased cost-effectiveness and reach, particularly when it comes to extending access outside of cities. However, region-specific infrastructure deficiencies, untrained staff for decentralization operations, and absence of e-consent provisions in New Drugs and Clinical Trial Rules 2019, restricts scalability. The 2024 draft guidance of United States’s Food and Drug Administration provides framework for decentralized clinical trials which can be implemented in India. In order to ensure ethical, and successful implementation of decentralized clinical trials for India's diverse healthcare system investment in digital health infrastructure, regulatory revisions, and site personnel training for decentralized clinical trial operations is necessary.
Metrics
References
Harmon D, Noseworthy P, Yao X. The digitization and decentralization of clinical trials. Mayo Clin Proceed. 2023;98(10):1568-78. DOI: https://doi.org/10.1016/j.mayocp.2022.10.001
Moogi A, Kalyandurgamath K. A Review of Significance of Decentralized Clinical Trials in India and Impact of Data Analytics in Clinical Data. YMER Digital. 2022;21(12).
Vayena E, Blasimme A, Sugarman J. Decentralised clinical trials: ethical opportunities and challenges. Lancet Digital Health. 2023;5:390-4. DOI: https://doi.org/10.1016/S2589-7500(23)00052-3
Izem R, Zuber E, Daizadeh N, Bretz F, Sverdlov O, Edrich P, et al. Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework. Ther Innov Regul Sci. 2024;58(3):495-504. DOI: https://doi.org/10.1007/s43441-024-00615-8
Bassi A, Arfin S, Joshi R, Bathla N, Hammond N, Rajbhandari D, et al. Complexity of clinical trial operationalisation in India. Lancet Global Health. 2022;10:953. DOI: https://doi.org/10.1016/S2214-109X(22)00209-1
StriderDCT. Pioneers in decentralized clinical trials in India. Available at: https://striderdct.com. Accessed on 18 April 2025.
Karkinos Healthcare. Ushering the era of decentralised oncology clinical trials in India. Available at: https://www.karkinos.in/ushering-the-era-of-decentralised-oncology. Accessed on 18 April 2025.
Clinical Trials Arena. DCT tracker: Tracing industry’s adoption of decentralised clinical trials. 2024. Available at: https://www.clinicaltrialsarena. com/features/dct-adoption-tracker-who-and-what-is-at-the-crest-of-the-trial-decentralisation-wave/. Accessed on 21 April 2025.
Economic Times Healthworld. Digital literacy a key factor for Decentralised Clinical Trials in India: ICMR Scientist. 2023. Available at: https://health. economictimes.indiatimes.com/news/pharma/pharma-industry/digital-literacy-a-key-factor-for-decentralised-clinical-trials-in-india-icmr-scientist/110208346. Accessed on 22 April 2025.
Clival. Decentralized clinical trials in India: Bridging the gap for rural and remote areas. 2025. Available at: https://clival.com/blog/decentralized-clinical-trials-in-india Accessed on 24 April 2025.
NIIT Foundation. Bridging the digital divide: Empowering rural India. 2024. Available at: https://niitfoundation.org/bridging-the-digital-divide-empowering-rural-india Accessed on 24 April 2025.
Biotechnology Industry Research Assistance Council. Clinical trial network report. 2023. Available at: https://www.birac.nic.in/webcontent/ 1733477854_ctn.pdf. Accessed on 25 April 2025.
Association of Clinical Research Professionals. Unique considerations for patient retention in decentralized clinical trials. 2023. Available at: https://acrpnet.org/2023/02/22/unique-consideration s-for-patient-retention-in-decentralized-clinical-trials/. Accessed on 27 April 2025.
Thread Research. Decentralized clinical trial tools that increase patient retention. 2021. Available at: https://www.threadresearch.com/blog/decentralized-clinical-trial-tools-that-increase-patient-retention. Accessed on 29 April 2025.
PwC India. Clinical trial opportunities in India. 2022. Available at: https://www.pwc.in/assets/pdfs/consul ting/management- consulting/clinical- trial-oppor tunities-in-india.pdf. Accessed on 29 April 2025.
ArcheMedX. A decentralized clinical trial requires training at scale. 2020. Available at: https://www. archemedx.com/corp-blog/a-decentralized-clinical-trial-means-training-at-scale/. Accessed on 29 April 2025.
Puri S, Ranjan J. Study of logistics issues in the Indian pharmaceutical industry. Int J Logistics Economics Globalisation. 2012;4(3):150-61. DOI: https://doi.org/10.1504/IJLEG.2012.050204
Yourway Transport. Direct-to-patient logistics: A patient-centric supply chain approach to decentralized virtual clinical trials. 2022. Available at: https://www.yourway.com/blog/direct-to-patient-logistics-a-patientcentric-supply-chain-approach-to-decentralized-virtual-clinical-trials. Accessed on 30 April 2025.
19. DHL. Patient centric delivery for clinical trials of the future. 2023. Available at: https://www.dhl.com/ in-en/home/insights/patient-centric-delivery-for-clinical-trials-of-the-future.html. Accessed on 30 April 2025.
Central Drugs Standard Control Organization. New Drugs and Clinical Trials Rules. 2019. Available at: https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2022/new_DC_rules/NEW%20DRUGS%20ANDctrS%20RULE%2C%202019.pdf. Accessed on 01 May 2025.
Rajiv Gandhi Centre for Biotechnology. Policy recommendations for strengthening clinical research ecosystem in India. 2022. Available at: https://rgcb.res.in/uploads/Policy-Recommendations -Clinical-Research. Accessed on 01 May 2025.
Ministry of Health and Family Welfare, Government of India. Telemedicine practice guidelines: Enabling registered medical practitioners to provide healthcare using telemedicine. 2020. Available at: https://www. mohfw.gov.in/pdf/Telemedicine.pdf. Accessed on 01 May 2025.
Ministry of Health and Family Welfare, Government of India. eSanjeevani: A doctor to patient telemedicine service. 2024. Available at: https://esanjeevani.mohfw.gov.in/. Accessed on 01 May 2025.
Intelehealth. Leveraging telemedicine for expanding access to healthcare in rural India. 2023. Available at: https://www.intelehealth.org/. Accessed on 02 May 2025.
U.S. Food and Drug Administration. Conducting clinical trials with decentralized elements. 2024. Available at: https://www.fda.gov/regulatory-inform ation/search-fda-guidance-documents/conducting-clinical-trials-decentralized-elements. Accessed on 02 May 2025.
European Medicines Agency. Facilitating decentralised clinical trials in the EU. 2022. Available at: https://www.ema.europa.eu/en/news/ facilitating-decentralised-clinical-trials-eu. Accessed on 02 May 2025.
Samisti Legal. Reforming clinical trials in India: A new era for clinical research organizations. 2024. Available at: https://samistilegal.in/reforming-clinical-trials-in-india-a-new-era-for-clinical-research-organizations/. Accessed on 03 May 2025.
Biorasi. Spotlight on India: Regulatory enhancements, modernization, and robust data collection define India as a potential clinical trial hub. 2023. Available at: https://biorasi.com/insight/ spotlight-on-india-regulatory-enhancements-modernization-and-robust-data-collection-define-india-as-a-potential-clinical-trial-hub. Accessed on 03 May 2025.
Knudsen KS, Becker KD, Guan K, Gellatly R, Patel VH, Malik K, et al. A pilot study to evaluate feasibility and acceptability of training mental health workers in India to select case-specific intervention procedures within a dynamic modular treatment designed for a low-resource setting. J Eval Clin Pract. 2022;28(4):531-41. DOI: https://doi.org/10.1111/jep.13623
Downloads
Published
How to Cite
Issue
Section
